S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
ETR:RHK

RHÖN-KLINIKUM Aktiengesellschaft (RHK) Stock Price, News & Analysis

€10.80
-0.30 (-2.70%)
(As of 04/17/2024 ET)
Today's Range
€10.80
€11.00
50-Day Range
€9.60
€12.30
52-Week Range
€9.50
€13.70
Volume
439 shs
Average Volume
43,281 shs
Market Capitalization
$722.95 million
P/E Ratio
22.04
Dividend Yield
1.39%
Price Target
N/A
RHK stock logo

About RHÖN-KLINIKUM Aktiengesellschaft Stock (ETR:RHK)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

RHK Stock Price History

RHK Stock News Headlines

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Shares Up 1.8%
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Rhön-Klinikum kommt gut durchs Corona-Jahr 2021
RHÖN-KLINIKUM Campus Bad Neustadt ist TAVI-Zentrum
See More Headlines
Receive RHK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
18,158
Year Founded
N/A

Profitability

Net Income
$31.92 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.71 billion
Cash Flow
€3.93 per share
Book Value
€19.14 per share

Miscellaneous

Free Float
N/A
Market Cap
$722.95 million
Optionable
Not Optionable
Beta
-0.01
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Tobias Kaltenbach (Age 64)
    Chairman of Management Board
    Comp: $547k
  • Dr. Stefan Stranz (Age 47)
    CFO & Member of Management Board
    Comp: $668k
  • Dr. Gunther Karl Weiß M.Sc. (Age 56)
    COO & Member of Management Board
    Comp: $708k
  • Julian Schmitt
    Head of Investor Relations & Treasury
  • Mr. Eugen Münch
    Chief Representative

RHK Stock Analysis - Frequently Asked Questions

How have RHK shares performed in 2024?

RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at €10.00 on January 1st, 2024. Since then, RHK stock has increased by 8.0% and is now trading at €10.80.
View the best growth stocks for 2024 here
.

Is RHÖN-KLINIKUM Aktiengesellschaft a good dividend stock?

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) pays an annual dividend of €0.15 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 30.61%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft own?
This page (ETR:RHK) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners